- Bio Protocol’s native token (BIO) surged 56% to $0.1238 within 24 hours after listing on South Korea’s leading crypto exchange Upbit.
- A network update introduced advanced AI-driven BioAgents, multi-chain support, and other developments crucial to the Bio Protocol ecosystem.
- BIO’s market capitalization rose to approximately $196,000,000.
Bio Protocol’s native token experienced a sharp rally, climbing 56% over the past 24 hours to reach $0.1238, with trading volume topping $164,000,000.
This rebound followed the token’s listing on Upbit, one of South Korea’s most influential cryptocurrency exchanges.
Bio Protocol Price Jumps Following Upbit Listing
After a month-long downtrend, Bio Protocol (BIO) is showing signs of recovery.
Since October 1, the token had been sliding from around $0.15 to a low near $0.078.
The announcement of BIO’s Upbit listing served as the immediate catalyst for the explosive price move.
Upbit accounts for more than 80% of South Korea’s crypto trading volume and has a track record of propelling altcoins to new highs.
At the time of writing, BIO’s 24-hour trading volume surged 820% to $311,550,000.
This listing builds on earlier exchange momentum after BIO debuted on Binance and Kraken.
According to CoinMarketCap data, BIO is currently trading around $0.11, having broken above resistance near $0.09, and its market cap is close to $196,000,000.
Traders caution that a broader market pullback could trigger a correction and emphasize the need for sustained adoption rather than speculative hype.
BIO Soars on Major Network Update
Excitement around a recent, significant network update for Bio Protocol continued to amplify the momentum created by the Upbit listing.
The upgrade reinvigorated community engagement and introduced several key enhancements.
The update strengthened Bio Protocol’s staking mechanisms.
It also integrated BioAgents—AI-powered research assistants designed to automate hypothesis generation and experiment tracking.
“From AI co-scientists to biotech intellectual property, over 8,000 participants joined the first wave of new Bio Launchpad projects. These tokenized AI co-scientists and biotech IP allow the community to fund and own breakthroughs in stem cell research, male health, and brain health. Each project launched on-chain vaults and liquidity, creating an aligned incentive community around real-world science.”
Although temporary network slowdowns have affected short-term community sentiment, Bio Protocol’s ability to tie biotech innovation to decentralized governance is significant for BIO’s long-term potential.
The project is redefining industry standards and giving investors a unique way to participate in a transformative ecosystem.
Stakeholders are advised to monitor upcoming milestones, including the rollout of new BioXP rewards and ongoing cross-chain development.
Current market conditions could present obstacles to further gains. However, with the Upbit listing and recent upgrades in place, buyers may target a near-term peak around $0.43. Clearing that level could put BIO on a path toward its historical high of $0.92 reached in January 2025.